Kristine B Walhovd1, Astrid Bjørnebekk2, Kristin Haabrekke3, Torill Siqveland4, Kari Slinning3, Egil Nygaard5, Anders M Fjell2, Paulina Due-Tønnessen6, Atle Bjørnerud7, Vibeke Moe3. 1. Research Group for Lifespan Changes in Brain and Cognition, Department of Psychology, University of Oslo, Norway; Department of Physical Medicine and Rehabilitation, Unit of Neuropsychology, Oslo University Hospital, Oslo, Norway. Electronic address: k.b.walhovd@psykologi.uio.no. 2. Research Group for Lifespan Changes in Brain and Cognition, Department of Psychology, University of Oslo, Norway; Department of Physical Medicine and Rehabilitation, Unit of Neuropsychology, Oslo University Hospital, Oslo, Norway. 3. The Center for Child and Adolescent Mental Health, Eastern and Southern Norway, Oslo, Norway; Department of Psychology, University of Oslo, Oslo, Norway. 4. Department of Psychology, University of Oslo, Oslo, Norway. 5. Research Group for Lifespan Changes in Brain and Cognition, Department of Psychology, University of Oslo, Norway. 6. Research Group for Lifespan Changes in Brain and Cognition, Department of Psychology, University of Oslo, Norway; Department of Radiology, Section of Neuroradiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. 7. Research Group for Lifespan Changes in Brain and Cognition, Department of Psychology, University of Oslo, Norway; Intervention Center, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Abstract
BACKGROUND: Maternal opioid and polysubstance use during pregnancy is associated with an increased risk of child neurocognitive and visual problems and neuroanatomical differences. We hypothesized that, in contrast to findings from a previous study of children born to mothers not detoxified, children born to detoxified mothers would not show gross neuroanatomical and neurocognitive differences. METHODS: Mothers with opioid and polysusbstance abuse problems and their infants (n = 11 + 12) were recruited from residential treatment institutions. Comparison mothers and infants (n = 12 + 12) were recruited from child health centers. The studies were approved by the Regional Committee of Medical Research Ethics. Children had magnetic resonance imaging scanning, neurocognitive, and visual acuity testing at 4.5 years. Neuroanatomical, cognitive, and visual acuity characteristics were compared across groups by analysis of variance and general linear models. RESULTS: There were no significant differences across groups in neuroanatomical volumes, or cortical thickness, area, or volume. There were no differences in general neurocognitive functioning, but significantly lower left eye visual acuity, and a trend toward lower binocular visual acuity, in the drug-exposed relative to the comparison group. CONCLUSIONS: The present study does not demonstrate gross differences relative to a comparison group in neuroanatomical and general neurocognitive characteristics of children born to mothers with opioid and polysubstance abuse who were detoxified during pregnancy. However, visual acuity was significantly lower in the drug-exposed group, requiring attention. There is a pressing need for additional and larger studies of long-term and specific child outcomes in this at-risk group.
BACKGROUND: Maternal opioid and polysubstance use during pregnancy is associated with an increased risk of child neurocognitive and visual problems and neuroanatomical differences. We hypothesized that, in contrast to findings from a previous study of children born to mothers not detoxified, children born to detoxified mothers would not show gross neuroanatomical and neurocognitive differences. METHODS: Mothers with opioid and polysusbstance abuse problems and their infants (n = 11 + 12) were recruited from residential treatment institutions. Comparison mothers and infants (n = 12 + 12) were recruited from child health centers. The studies were approved by the Regional Committee of Medical Research Ethics. Children had magnetic resonance imaging scanning, neurocognitive, and visual acuity testing at 4.5 years. Neuroanatomical, cognitive, and visual acuity characteristics were compared across groups by analysis of variance and general linear models. RESULTS: There were no significant differences across groups in neuroanatomical volumes, or cortical thickness, area, or volume. There were no differences in general neurocognitive functioning, but significantly lower left eye visual acuity, and a trend toward lower binocular visual acuity, in the drug-exposed relative to the comparison group. CONCLUSIONS: The present study does not demonstrate gross differences relative to a comparison group in neuroanatomical and general neurocognitive characteristics of children born to mothers with opioid and polysubstance abuse who were detoxified during pregnancy. However, visual acuity was significantly lower in the drug-exposed group, requiring attention. There is a pressing need for additional and larger studies of long-term and specific child outcomes in this at-risk group.
Authors: Mishka Terplan; Hollis J Laird; Dennis J Hand; Tricia E Wright; Ashish Premkumar; Caitlin E Martin; Marjorie C Meyer; Hendrée E Jones; Elizabeth E Krans Journal: Obstet Gynecol Date: 2018-05 Impact factor: 7.661
Authors: Rupa Radhakrishnan; Brandon P Brown; David M Haas; Yong Zang; Christina Sparks; Senthilkumar Sadhasivam Journal: J Neuroradiol Date: 2021-01-05 Impact factor: 3.447
Authors: Elisabeth Conradt; Tess Flannery; Judy L Aschner; Robert D Annett; Lisa A Croen; Cristiane S Duarte; Alexander M Friedman; Constance Guille; Monique M Hedderson; Julie A Hofheimer; Miranda R Jones; Christine Ladd-Acosta; Monica McGrath; Angela Moreland; Jenae M Neiderhiser; Ruby H N Nguyen; Jonathan Posner; Judith L Ross; David A Savitz; Steven J Ondersma; Barry M Lester Journal: Pediatrics Date: 2019-09 Impact factor: 9.703
Authors: Su Lynn Yeoh; John Eastwood; Ian M Wright; Rachael Morton; Edward Melhuish; Meredith Ward; Ju Lee Oei Journal: JAMA Netw Open Date: 2019-07-03
Authors: Lauren E Kelly; Lauren M Jansson; Wendy Moulsdale; Jodi Pereira; Sarah Simpson; Astrid Guttman; Karel Allegaert; Lisa Askie; Henry Roukema; Thierry Lacaze; Jonathan M Davis; Loretta Finnegan; Paula Williamson; Martin Offringa Journal: Trials Date: 2016-11-08 Impact factor: 2.279